Current Pharmacotherapy of Depression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ham, Byung-Joo | - |
dc.contributor.author | Jung, In-Kwa | - |
dc.date.accessioned | 2021-09-08T17:38:19Z | - |
dc.date.available | 2021-09-08T17:38:19Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2009-05 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/120150 | - |
dc.description.abstract | Currently, pharmacotherapy is the primary treatment modality for depression. Various classes of antidepressants have been developed and are widely used at present. Although the antidepressant effects of these drugs are thought to be similar, there are numerous differences between drugs in pharmacologic characteristics, side effects, and tolerabilities. Furthermore, 40 similar to 50% of patients may not respond sufficiently to the first-line antidepressants they take. As the response rates are substantially insufficient, and the side effects are not uncommon, the optimal treatment of antidepressants is somewhat difficult. Therefore, the clinicians treating depression should understand the characteristics of various antidepressants and also the optimal treatment strategy. In this review, we introduce various antidepressants and optimal treatment strategies for the treatment of depression. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.publisher | KOREAN MEDICAL ASSOC | - |
dc.title | Current Pharmacotherapy of Depression | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ham, Byung-Joo | - |
dc.identifier.doi | 10.5124/jkma.2009.52.5.518 | - |
dc.identifier.scopusid | 2-s2.0-79955803486 | - |
dc.identifier.wosid | 000266124000011 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.52, no.5, pp.518 - 524 | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.title | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 52 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 518 | - |
dc.citation.endPage | 524 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001342151 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordAuthor | Depression | - |
dc.subject.keywordAuthor | Pharmacotherapy | - |
dc.subject.keywordAuthor | Antidepressants | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.